Relationship of aging and cardiac IL-10

Victoria Dotson1, Katherine Horak, Cory Alwardt

  • 1The Circulatory Science Graduate Perfusion Program, Department of Surgery, College of Medicine, The University of Arizona, Tucson, Arizona 85724, USA.

Insights

Aging impairs heart regeneration after myocardial infarction by increasing Interleukin-10 (IL-10). This reduces stem cell proliferation, hindering repair. Modulating IL-10 may optimize cardiac healing in older patients.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Aging Biology

Background:

  • Current heart failure and myocardial infarction therapies are limited by the inability of cardiac cells to regenerate.
  • Stem cell therapy offers potential but faces challenges in stem cell recruitment and engraftment in damaged heart tissue.
  • Age-related changes in the heart may impede the necessary molecular signaling for effective stem cell integration.

Purpose of the Study:

  • To investigate the role of Interleukin-10 (IL-10) in age-related impairment of cardiac regeneration following myocardial injury.
  • To test the hypothesis that elevated IL-10 in aged individuals reduces cardiac cellular proliferation and stem cell response after heart attack.

Main Methods:

  • Analysis of cardiac gene expression in aging models and human myocardial infarction samples.
  • Correlation of IL-10 levels with cellular proliferation in the border regions of infarcted myocardium.
  • Review of existing literature on aging, IL-10, and tissue repair.

Main Results:

  • Demonstrated increased cardiac gene expression of IL-10 in aged subjects.
  • Observed a reduced proliferative response in the infarcted myocardium of older individuals, proportional to age.
  • Found elevated IL-10 levels in aging models are linked to diminished healing responses in various tissues.

Conclusions:

  • Overexpression of IL-10 in aged populations contributes to reduced cardiac cellular proliferation after myocardial infarction.
  • Age-related increases in IL-10 may be a key factor limiting the regenerative capacity of the heart.
  • Targeting IL-10 therapeutically could enhance stem cell engraftment and promote myocardial repair in elderly patients with heart conditions.

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...